Skip to main content
Ondine Biomedical Inc. logo

Ondine Biomedical Inc. — Investor Relations & Filings

Ticker · OBI ISIN · CA68234M2058 LEI · 9845005B69E07CGF4A56 TSXV Manufacturing
Open in API
Filings indexed 223 across all filing types
Latest filing 2026-03-10 Regulatory Filings
Country CA Canada
Listing TSXV OBI

About Ondine Biomedical Inc.

https://ondinebio.com/

Ondine Biomedical Inc. is a life sciences company that develops and commercializes photodisinfection-based therapies to prevent and treat a broad spectrum of infections, including those caused by drug-resistant pathogens. The company's patented platform technology involves applying a photosensitive agent to a targeted area, followed by illumination with non-thermal laser light. This process creates an oxidative burst that rapidly destroys pathogens like bacteria, viruses, and fungi without inducing microbial resistance. Its lead product, Steriwave™, is a nasal decolonization therapy used to eradicate pathogens in the nasal cavity, primarily to reduce the risk of healthcare-associated infections (HAIs) such as post-operative surgical site infections. The company's product pipeline is exploring applications for chronic rhinosinusitis, burns, wounds, and ventilator-associated pneumonia.

Recent filings

Filing Released Lang Actions
Ondine Provides Update on US Phase 3 Pivotal Study
Regulatory Filings Classification · 95% confidence The document is an RNS (Regulatory News Service) announcement from Ondine Biomedical Inc. regarding an operational update on their Phase 3 clinical trial (LANTERN study). It provides progress metrics and confirms the timeline for reporting results. Since it is a regulatory announcement regarding company operations and clinical trial status, and does not fit into specific categories like financial reports or shareholder voting, it is classified as a Regulatory Filing (RNS).
2026-03-10 English
Holdings in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'Standard form for notification of major holdings' (TR-1 form) filed via the London Stock Exchange's RNS service. It details a change in shareholding by Pentwater Capital Management LP in Ondine Biomedical Inc. This falls directly under the definition of a Major Shareholding Notification (MRQ).
2026-03-03 English
Share Issuance for ICU Study Submission
Share Issue/Capital Change Classification · 100% confidence The document is an official announcement from Ondine Biomedical Inc. regarding the issuance of new common shares as a milestone payment for a clinical trial agreement. It details the number of shares issued, the issue price, the impact on total voting rights, and the admission of these shares to the AIM market. This falls under the category of share issuance and capital changes.
2026-02-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a 'TR-1: Standard form for notification of major holdings', which is the regulatory standard in the UK for disclosing significant changes in share ownership (threshold notifications). It explicitly details the percentage of voting rights held by M&G Plc in Ondine Biomedical Inc. This aligns perfectly with the definition of a Major Shareholding Notification (MRQ).
2026-02-20 English
Ondine and Mid Yorks Win National Award
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the London Stock Exchange's 'Reach' service, which is a non-regulatory news distribution platform. It announces that Ondine Biomedical Inc. and Mid Yorkshire Teaching NHS Trust have won a healthcare partnership award. As this is a corporate news announcement regarding company activities and awards that does not fit into specific financial reporting categories like 10-K, IR, or ER, it falls under the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2026-02-06 English
Steriwave Up for 2025 “Product of the Year” Award
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the RNS Reach service regarding a company's product being shortlisted for an industry award. It does not contain financial statements, regulatory filings, or specific corporate governance disclosures. As it is a general corporate announcement that does not fit into the specific categories like 10-K, ER, or MANG, it falls under the RNS (Regulatory Filings) category as a general regulatory/corporate announcement.
2026-02-02 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.